New Key Statistics Module, Z-Score and F-Score
NAS:COCP Key Ratios
| Market Cap $ M | 23.50 |
| Enterprise Value $ M | 22.67 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 15.25 |
| Price/Sales | 50.83 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.76 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 31.40 |
| 5-y EBITDA Growth Rate % | 13.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.24 |
| EV-to-EBITDA | -2.32 |
| PEG | -- |
| Shares Outstanding M | 19.26 |
| Net Margin (%) | -3,011.52 |
| Operating Margin % | -3,063.64 |
| Pre-tax Margin (%) | -3,011.52 |
| Quick Ratio | 1.24 |
| Current Ratio | 1.24 |
| ROA % (ttm) | -121.97 |
| ROE % (ttm) | -202.87 |
| ROIC % (ttm) | -492.35 |
| Dividend Yield % | -- |
| Altman Z-Score | -107.73 |
COCP Number of Guru Trades
COCP Volume of Guru Trades
Gurus Latest Trades with NAS:COCP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:COCP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cocrystal Pharma Inc Insider Transactions
No Available Data
News about NAS:COCP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers